In another study, the therapeutic administration of a monoclonal antibody against the granulocyte-colony-stimulating factor receptor (G-CSFR mAb) during Streptococcus pneumoniae infection significantly reduced blood and airway neutrophil numbers without affecting bacterial load [44]. The gene discussed is CSF3R; the disease is pneumococcal infection.